{"transactions":[{"id":730655,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-06-22T20:15:14.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from June 17, 2026; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":3.62,"expiration_date":"2036-06-17","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001867508-26-000002","document":"form4-06222026_040609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000186750826000002/form4-06222026_040609.xml","form_type":"4"}},{"id":1137419,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-05-22T21:35:36.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from May 21, 2025; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":1.03,"expiration_date":"2035-05-21","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001415889-25-014219","document":"form4-05222025_090531.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925014219/form4-05222025_090531.xml","form_type":"4"}},{"id":1335862,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-12-11T21:45:15.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":117000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from October 23, 2024; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":117000,"derivative":{"exercise_price":2.76,"expiration_date":"2034-12-09","underlying":"Class A Ordinary Shares","underlying_shares":117000},"source":{"system":"sec-edgar","filing":"0001415889-24-028976","document":"form4-12112024_041211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924028976/form4-12112024_041211.xml","form_type":"4"}},{"id":1882816,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Share Option (Right to Buy)","published_at":"2023-05-23T01:18:35.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":7652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become fully exercisable on the earlier of (i) May 18, 2024 or (ii) the date of the next annual meeting of shareholders of Zura Bio Limited."}],"balance_after":7652,"derivative":{"exercise_price":5.31,"expiration_date":"2033-05-18","underlying":"Class A Ordinary Shares","underlying_shares":7652},"source":{"system":"sec-edgar","filing":"0001104659-23-063320","document":"tm2316481-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923063320/tm2316481-10_4seq1.xml","form_type":"4"}},{"id":2177478,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-22T18:12:54.000Z","date":"2022-08-20","kind":"tax_withholding","acquired":false,"shares":4782,"price":3.33,"value":15924.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The closing price on August 19, 2022, the fair market used for the transaction date."}],"balance_after":211663,"source":{"system":"sec-edgar","filing":"0001209191-22-047068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919122047068/doc4.xml","form_type":"4"}},{"id":2248484,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-06-02T16:28:38.000Z","date":"2022-06-01","kind":"tax_withholding","acquired":false,"shares":4782,"price":2.82,"value":13485.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The closing price on June 1, 2022, the transaction date."}],"balance_after":216445,"source":{"system":"sec-edgar","filing":"0001209191-22-033530","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919122033530/doc4.xml","form_type":"4"}},{"id":2338172,"issuer":{"id":94856,"kind":"organization","name":"ARENA PHARMACEUTICALS INC"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-11T16:22:28.000Z","date":"2022-03-11","kind":"disposition_to_issuer","acquired":false,"shares":7202,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase Issuer Common Stock (each, an \"Issuer Option\") granted by Issuer under the Issuer's 2021 Long-Term Incentive Plan or prior stock plans (collectively, the \"Issuer Stock Plans\") that was outstanding as of immediately prior to the Effective Time, whether or not then vested, was cancelled and immediately ceased to be outstanding and was converted into the right to receive an amount in cash equal to the product of (1) the excess, if any, of the Merger Consideration over the per-share exercise price of such Issuer Option, multiplied by (2) the number of Issuer Common Stock then subject to such Issuer Option, subject to any required withholding of taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase Issuer Common Stock (each, an \"Issuer Option\") granted by Issuer under the Issuer's 2021 Long-Term Incentive Plan or prior stock plans (collectively, the \"Issuer Stock Plans\") that was outstanding as of immediately prior to the Effective Time, whether or not then vested, was cancelled and immediately ceased to be outstanding and was converted into the right to receive an amount in cash equal to the product of (1) the excess, if any, of the Merger Consideration over the per-share exercise price of such Issuer Option, multiplied by (2) the number of Issuer Common Stock then subject to such Issuer Option, subject to any required withholding of taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase Issuer Common Stock (each, an \"Issuer Option\") granted by Issuer under the Issuer's 2021 Long-Term Incentive Plan or prior stock plans (collectively, the \"Issuer Stock Plans\") that was outstanding as of immediately prior to the Effective Time, whether or not then vested, was cancelled and immediately ceased to be outstanding and was converted into the right to receive an amount in cash equal to the product of (1) the excess, if any, of the Merger Consideration over the per-share exercise price of such Issuer Option, multiplied by (2) the number of Issuer Common Stock then subject to such Issuer Option, subject to any required withholding of taxes."}],"balance_after":0,"derivative":{"exercise_price":65.19,"underlying":"Common Stock","underlying_shares":7202},"source":{"system":"sec-edgar","filing":"0001628280-22-005911","document":"wf-form4_164703373333678.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1080709/000162828022005911/wf-form4_164703373333678.xml","form_type":"4"}},{"id":2338171,"issuer":{"id":94856,"kind":"organization","name":"ARENA PHARMACEUTICALS INC"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-11T16:22:28.000Z","date":"2022-03-11","kind":"disposition_to_issuer","acquired":false,"shares":3601,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase Issuer Common Stock (each, an \"Issuer Option\") granted by Issuer under the Issuer's 2021 Long-Term Incentive Plan or prior stock plans (collectively, the \"Issuer Stock Plans\") that was outstanding as of immediately prior to the Effective Time, whether or not then vested, was cancelled and immediately ceased to be outstanding and was converted into the right to receive an amount in cash equal to the product of (1) the excess, if any, of the Merger Consideration over the per-share exercise price of such Issuer Option, multiplied by (2) the number of Issuer Common Stock then subject to such Issuer Option, subject to any required withholding of taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase Issuer Common Stock (each, an \"Issuer Option\") granted by Issuer under the Issuer's 2021 Long-Term Incentive Plan or prior stock plans (collectively, the \"Issuer Stock Plans\") that was outstanding as of immediately prior to the Effective Time, whether or not then vested, was cancelled and immediately ceased to be outstanding and was converted into the right to receive an amount in cash equal to the product of (1) the excess, if any, of the Merger Consideration over the per-share exercise price of such Issuer Option, multiplied by (2) the number of Issuer Common Stock then subject to such Issuer Option, subject to any required withholding of taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase Issuer Common Stock (each, an \"Issuer Option\") granted by Issuer under the Issuer's 2021 Long-Term Incentive Plan or prior stock plans (collectively, the \"Issuer Stock Plans\") that was outstanding as of immediately prior to the Effective Time, whether or not then vested, was cancelled and immediately ceased to be outstanding and was converted into the right to receive an amount in cash equal to the product of (1) the excess, if any, of the Merger Consideration over the per-share exercise price of such Issuer Option, multiplied by (2) the number of Issuer Common Stock then subject to such Issuer Option, subject to any required withholding of taxes."}],"balance_after":0,"derivative":{"exercise_price":65.19,"underlying":"Common Stock","underlying_shares":3601},"source":{"system":"sec-edgar","filing":"0001628280-22-005911","document":"wf-form4_164703373333678.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080709/000162828022005911/wf-form4_164703373333678.xml","form_type":"4"}},{"id":2338170,"issuer":{"id":94856,"kind":"organization","name":"ARENA PHARMACEUTICALS INC"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-11T16:22:28.000Z","date":"2022-03-11","kind":"other","acquired":false,"shares":4600,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\"), dated December 12, 2021, by and among the Issuer, Pfizer Inc. (\"Parent\") and Antioch Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger (the \"Merger\") between Issuer and Merger Sub on March 11, 2022. Pursuant to the Merger Agreement, as of the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock, $0.0001 par value per share (\"Issuer Common Stock\"), was cancelled, retired and converted into the right to receive an amount equal to $100.00 in cash, without interest thereon (the \"Merger Consideration\"), subject to any required withholding of taxes."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit subject to vesting conditions based solely on continued employment or service to the Issuer or any of its subsidiaries granted by the Issuer under an Issuer Stock Plan, except any restricted stock unit that was granted after December 12, 2021, (each, an \"Issuer RSU\"), that was unvested and outstanding as of immediately prior to the Effective Time was cancelled and immediately ceased to be outstanding and was converted into the right to receive an amount in cash equal to the Merger Consideration, subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit subject to vesting conditions based solely on continued employment or service to the Issuer or any of its subsidiaries granted by the Issuer under an Issuer Stock Plan, except any restricted stock unit that was granted after December 12, 2021, (each, an \"Issuer RSU\"), that was unvested and outstanding as of immediately prior to the Effective Time was cancelled and immediately ceased to be outstanding and was converted into the right to receive an amount in cash equal to the Merger Consideration, subject to any required withholding of taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-22-005911","document":"wf-form4_164703373333678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080709/000162828022005911/wf-form4_164703373333678.xml","form_type":"4"}},{"id":2402905,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-11T16:33:34.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":487127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of stock options under the Plan.  The stock options vest equally in 1/48 monthly installments commencing on March 9, 2022.  The vesting of the options is subject to continued service for the Company, the terms and conditions of the applicable award agreement, and applicable tax withholding obligations."}],"balance_after":487127,"derivative":{"exercise_price":5,"expiration_date":"2032-02-09","underlying":"Class A Common Stock","underlying_shares":487127},"source":{"system":"sec-edgar","filing":"0001209191-22-008893","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919122008893/doc4.xml","form_type":"4"}},{"id":2402904,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-11T16:33:34.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":221227,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (the \"RSUs\") under the 23andMe Holding Co's (the \"Company\") 2021 Incentive Equity Plan (the \"Plan\"). The RSUs vest equally in 1/16 quarterly installments commencing on May 20, 2022. The vesting of the RSUs is subject to continued service for the Company, the terms and conditions of the applicable award agreement, and applicable tax withholding obligations. Each RSU represents the contingent right to receive one share of Class A common stock of the Company."}],"balance_after":221227,"source":{"system":"sec-edgar","filing":"0001209191-22-008893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919122008893/doc4.xml","form_type":"4"}},{"id":2669034,"issuer":{"id":94856,"kind":"organization","name":"ARENA PHARMACEUTICALS INC"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-15T17:23:21.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":7202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest in 12 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over one year beginning on July 11, 2021 with the final installment vesting  upon the earlier of the one-year anniversary of the grant date or the date of the next annual stockholders' meeting, and are exercisable once vested."}],"balance_after":7202,"derivative":{"exercise_price":65.19,"expiration_date":"2028-06-11","underlying":"Common Stock","underlying_shares":7202},"source":{"system":"sec-edgar","filing":"0001628280-21-012276","document":"wf-form4_162379214572153.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1080709/000162828021012276/wf-form4_162379214572153.xml","form_type":"4"}},{"id":2669033,"issuer":{"id":94856,"kind":"organization","name":"ARENA PHARMACEUTICALS INC"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-15T17:23:21.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":3601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in 36 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over three years beginning on July 11, 2021, and are exercisable once vested."}],"balance_after":3601,"derivative":{"exercise_price":65.19,"expiration_date":"2028-06-11","underlying":"Common Stock","underlying_shares":3601},"source":{"system":"sec-edgar","filing":"0001628280-21-012276","document":"wf-form4_162379214572153.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1080709/000162828021012276/wf-form4_162379214572153.xml","form_type":"4"}},{"id":2669032,"issuer":{"id":94856,"kind":"organization","name":"ARENA PHARMACEUTICALS INC"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-15T17:23:21.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":3067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The amount represents restricted stock units that vest in full on the earliest of June 11, 2022, or the date of Arena's next annual meeting of stockholders. The shares underlying the restricted stock units will be issued upon vesting and release of the restricted stock units."}],"balance_after":4600,"source":{"system":"sec-edgar","filing":"0001628280-21-012276","document":"wf-form4_162379214572153.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080709/000162828021012276/wf-form4_162379214572153.xml","form_type":"4"}},{"id":2669031,"issuer":{"id":94856,"kind":"organization","name":"ARENA PHARMACEUTICALS INC"},"owners":[{"id":36381,"kind":"person","name":"Schoch Steven J","position":1,"cik":"0001867508","reported_name":"Schoch Steven J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-15T17:23:21.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":1533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount represents restricted stock units that vest in three equal installments on the dates of Arena's next three annual meetings of stockholders. The shares underlying the restricted stock units will be issued upon vesting and release of the restricted stock units."}],"balance_after":1533,"source":{"system":"sec-edgar","filing":"0001628280-21-012276","document":"wf-form4_162379214572153.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080709/000162828021012276/wf-form4_162379214572153.xml","form_type":"4"}}]}